| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8829114 | Prostate International | 2016 | 5 Pages |
Abstract
The induction of SHTs prior to docetaxel therapy is an acceptable treatment option with some survival benefits for CRPC patients without pain and visceral metastases.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Shuya Kandori, Takayuki Yoshino, Masakazu Tsutsumi, Atsushi Yamauchi, Mikinobu Ohtani, Yoshiharu Fukuhara, Naoto Miyanaga, Jun Miyazaki, Hiroyuki Nishiyama, Toru Shimazui,